Physician

Carlos Paz, MD, PHD

According to 2025 Medicare claims, Carlos Paz, MD, PHD (NPI: 1275885709) practices dermatology in the Visalia, CA market, with the plurality of this provider's patient population coming from Tulare, CA. This provider's primary affiliated billing organization is FRESNO DERMATOLOGY SPECIALISTS, INC (NPI: 1891035127; TIN: 461924129) and primary practice location at 93291-5121.

Paz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,983 traditional Medicare patients, billed 16,932 HCPCS/CPT codes, and received $1,811,559 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 556 prescription claims across 404 beneficiaries totaling $7,469 in drug costs, led by Minocycline Hcl (Minocycline Hcl). Open Payments data shows 5 records totaling $193. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have fallen sharply in recent years, from $84,086 to $7,469. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.1M$2.1M2015 Medicare payment: $2,113,528 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,046,014 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,300,768 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,976,272 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,893,818 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,045,854 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,972,455 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,851,857 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,795,535 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,811,559 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201571813,443$2,113,528
201687011,756$1,046,014
20171,09412,246$1,300,768
20182,06720,844$1,976,272
20192,01723,550$1,893,818
20201,96722,425$2,045,854
20212,11019,646$1,972,455
20221,98817,658$1,851,857
20231,80613,790$1,795,535
20241,98316,932$1,811,559

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$62K$124K2015 Drug cost: $84,086 (USD; Tot_Drug_Cst)2016 Drug cost: $123,689 (USD; Tot_Drug_Cst)2017 Drug cost: $113,720 (USD; Tot_Drug_Cst)2018 Drug cost: $110,821 (USD; Tot_Drug_Cst)2019 Drug cost: $109,058 (USD; Tot_Drug_Cst)2020 Drug cost: $100,612 (USD; Tot_Drug_Cst)2021 Drug cost: $42,735 (USD; Tot_Drug_Cst)2022 Drug cost: $9,819 (USD; Tot_Drug_Cst)2023 Drug cost: $9,116 (USD; Tot_Drug_Cst)2024 Drug cost: $7,469 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015424962$84,086
20165461,303$123,689
20175731,376$113,720
20187241,748$110,821
20196551,531$109,058
20206951,634$100,612
20216791,477$42,735
2022473679$9,819
2023391516$9,116
2024404556$7,469

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths547613$87
11102Biopsy of related skin growth, first growth511596$67
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,1821,604$65
88305Pathology examination of tissue using a microscope, intermediate complexity1,1602,364$58
17000Destruction of precancer skin growth, 1 growth595718$38

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Minocycline HclMinocycline Hcl2882,042$2,084
CephalexinCephalexin106745$368
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen67270$255
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim43308$121
Ciprofloxacin HclCiprofloxacin Hcl23161$77

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$193REVANCE THERAPEUTICS, INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Carlos Paz, MD, PHD?

Tedicare shows public-source Medicare data for Carlos Paz, MD, PHD (NPI 1275885709), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carlos Paz, MD, PHD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Carlos Paz, MD, PHD?

Carlos Paz, MD, PHD is linked to FRESNO DERMATOLOGY SPECIALISTS, INC (billing NPI 1891035127) in the available physician profile data.

Does Carlos Paz, MD, PHD have Open Payments data?

Carlos Paz, MD, PHD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.